Mary Wilson
Well-known member
July 27, 2020
Clyde W. Yancy, MD, MSc[SUP]1,2[/SUP]; Gregg C. Fonarow, MD[SUP]3,4[/SUP]
JAMA Cardiol. Published online July 27, 2020. doi:10.1001/jamacardio.2020.3575
Multiple data sets now confirm the increased risk for morbid and mortal complications due to coronavirus disease 2019 (COVID-19) in individuals with preexisting cardiovascular diseases including hypertension, coronary artery disease, and heart failure.[SUP]1[/SUP][SUP],2[/SUP] These salient observations have strengthened preventive strategies and undoubtedly have resulted in lives saved. Although episodes of clinical myocarditis have been suspected and a few cases have been reported in the literature,[SUP]3[/SUP] direct cardiac involvement due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been difficult to confirm.
https://jamanetwork.com/journals/jamacardiology/fullarticle/2768915
Clyde W. Yancy, MD, MSc[SUP]1,2[/SUP]; Gregg C. Fonarow, MD[SUP]3,4[/SUP]
JAMA Cardiol. Published online July 27, 2020. doi:10.1001/jamacardio.2020.3575
Multiple data sets now confirm the increased risk for morbid and mortal complications due to coronavirus disease 2019 (COVID-19) in individuals with preexisting cardiovascular diseases including hypertension, coronary artery disease, and heart failure.[SUP]1[/SUP][SUP],2[/SUP] These salient observations have strengthened preventive strategies and undoubtedly have resulted in lives saved. Although episodes of clinical myocarditis have been suspected and a few cases have been reported in the literature,[SUP]3[/SUP] direct cardiac involvement due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been difficult to confirm.
https://jamanetwork.com/journals/jamacardiology/fullarticle/2768915